These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 38817601)

  • 41. [Assessment of bone quality. Bone remodeling and bone quality].
    Sano G; Matsuo K
    Clin Calcium; 2008 Mar; 18(3):315-20. PubMed ID: 18310818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiotrophin Like Cytokine Factor 1 (CLCF1) alleviates bone loss in osteoporosis mouse models by suppressing osteoclast differentiation through activating interferon signaling and repressing the nuclear factor-κB signaling pathway.
    Yokota S; Matsumae G; Shimizu T; Hasegawa T; Ebata T; Takahashi D; Heguo C; Tian Y; Alhasan H; Takahata M; Kadoya K; Terkawi MA; Iwasaki N
    Bone; 2021 Dec; 153():116140. PubMed ID: 34364014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Signaling pathways affecting skeletal health.
    Marie PJ
    Curr Osteoporos Rep; 2012 Sep; 10(3):190-8. PubMed ID: 22711369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.
    Sugatani T
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemokines in Physiological and Pathological Bone Remodeling.
    Brylka LJ; Schinke T
    Front Immunol; 2019; 10():2182. PubMed ID: 31572390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins.
    Loukas AT; Papadourakis M; Panagiotopoulos V; Zarmpala A; Chontzopoulou E; Christodoulou S; Katsila T; Zoumpoulakis P; Matsoukas MT
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling.
    Sapkota M; Gao M; Li L; Yang M; Shrestha SK; Choi H; Soh Y
    Eur J Pharmacol; 2020 Sep; 883():173305. PubMed ID: 32673673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection.
    Jones D; Glimcher LH; Aliprantis AO
    J Clin Invest; 2011 Jul; 121(7):2534-42. PubMed ID: 21737885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-Osteoporotic Effect of Morroniside on Osteoblast and Osteoclast Differentiation In Vitro and Ovariectomized Mice In Vivo.
    Lee CG; Kim J; Yun SH; Hwang S; Jeon H; Park E; Jeong SY
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular mechanisms in coupling of bone formation to resorption.
    Martin T; Gooi JH; Sims NA
    Crit Rev Eukaryot Gene Expr; 2009; 19(1):73-88. PubMed ID: 19191758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The intestinal microbiome and skeletal fitness: Connecting bugs and bones.
    Charles JF; Ermann J; Aliprantis AO
    Clin Immunol; 2015 Aug; 159(2):163-9. PubMed ID: 25840106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 'Osteoimmunology' Offers New Perspectives for the Treatment of Pathological Bone Loss.
    Liu H; Luo T; Tan J; Li M; Guo J
    Curr Pharm Des; 2017; 23(41):6272-6278. PubMed ID: 28494718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteoblast-osteoclast interactions.
    Chen X; Wang Z; Duan N; Zhu G; Schwarz EM; Xie C
    Connect Tissue Res; 2018 Mar; 59(2):99-107. PubMed ID: 28324674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon-gamma regulates the levels of bone formation effectors in a stage-dependent manner.
    Lai JH; Hsu YP; Yang CH; Chen YH; Liu CC; Chen SK
    Mol Biol Rep; 2022 Dec; 49(12):12007-12015. PubMed ID: 36273336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The positive effects of secreting cytokines IL-17 and IFN-γ on the early-stage differentiation and negative effects on the calcification of primary osteoblasts in vitro.
    Wang Z; Tan J; Lei L; Sun W; Wu Y; Ding P; Chen L
    Int Immunopharmacol; 2018 Apr; 57():1-10. PubMed ID: 29438885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracellular matrix networks in bone remodeling.
    Alford AI; Kozloff KM; Hankenson KD
    Int J Biochem Cell Biol; 2015 Aug; 65():20-31. PubMed ID: 25997875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoimmunology: The
    Dar HY; Azam Z; Anupam R; Mondal RK; Srivastava RK
    Front Biosci (Landmark Ed); 2018 Jan; 23(3):464-492. PubMed ID: 28930556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Newer therapies for osteoporosis.
    Palaniswamy C; Selvaraj DR; Rao V; Patel U
    Am J Ther; 2010; 17(2):197-200. PubMed ID: 20305400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts.
    Wu RW; Lian WS; Chen YS; Ko JY; Wang SY; Jahr H; Wang FS
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.